ATF4 and cancer: Both mTORC1 and GCN2-ATF4 signalling pathways are thus critically involved in the cell cycle, cell differentiation, and cell death [[24], [25], [26]], and their dysregulation is linked to multiple diseases, including cancer [19,27].